(E)-3-[2-chloro-6-(1-methylimidazol-4-yl)phenyl]-1-(4,4-difluorocyclohexyl)prop-2-en-1-one
C19H19ClF2N2O — CID 145029605
Data last refreshed: (MolForge compound catalog, from PubChem)
About (E)-3-[2-chloro-6-(1-methylimidazol-4-yl)phenyl]-1-(4,4-difluorocyclohexyl)prop-2-en-1-one
(E)-3-[2-chloro-6-(1-methylimidazol-4-yl)phenyl]-1-(4,4-difluorocyclohexyl)prop-2-en-1-one (PubChem CID 145029605) has the molecular formula C19H19ClF2N2O and a molecular weight of 364.82 g/mol. Its IUPAC name is (E)-3-[2-chloro-6-(1-methylimidazol-4-yl)phenyl]-1-(4,4-difluorocyclohexyl)prop-2-en-1-one.
Molecular Properties
| Compound Name | (E)-3-[2-chloro-6-(1-methylimidazol-4-yl)phenyl]-1-(4,4-difluorocyclohexyl)prop-2-en-1-one |
|---|---|
| PubChem CID | 145029605 |
| Molecular Formula | C19H19ClF2N2O |
| Molecular Weight | 364.82 g/mol |
| Exact Mass | 364.12 |
| IUPAC Name | (E)-3-[2-chloro-6-(1-methylimidazol-4-yl)phenyl]-1-(4,4-difluorocyclohexyl)prop-2-en-1-one |
| SMILES | Cn1cnc(-c2cccc(Cl)c2/C=C/C(=O)C2CCC(F)(F)CC2)c1 |
| InChI | InChI=1S/C19H19ClF2N2O/c1-24-11-17(23-12-24)15-3-2-4-16(20)14(15)5-6-18(25)13-7-9-19(21,22)10-8-13/h2-6,11-13H,7-10H2,1H3/b6-5+ |
| InChIKey | UZCLTELKZKKEML-AATRIKPKSA-N |
| XLogP | 5.15 |
| TPSA | 34.89 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 364.82 |
| LogP ≤ 5 | 5.15 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 145029605 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.